Positive news regarding Skyclarys® approval in the EU
Ataxia UK is delighted with today’s announcement from the EMA’s Committee for Medicinal Products for Human Use (CHMP), the regulatory body that makes recommendations on drug approvals in the EU. […]
Positive news regarding Skyclarys® approval in the EU Read More »